Savara (SVRA) Receives Composition of Matter Patent Covering AeroVanc

May 8, 2017 8:12 AM EDT Send to a Friend
Savara Inc. (NASDAQ: SVRA), a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login